MICHELLE NGUYEN: Open Payments
NPI 1740601269 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,694 in 127 payments from 21 companies in 2025. Trend: 2023 $1,702 · 2024 $1,472 · 2025 $3,694
Food & beverage: $2,739Travel & lodging: $955
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $955 |
| ABBVIE INC. | 28 | $400 |
| Otsuka America Pharmaceutical, Inc. | 15 | $342 |
| Janssen Pharmaceuticals, Inc | 9 | $327 |
| Teva Pharmaceuticals USA, Inc. | 21 | $322 |
| Neurocrine BioSciences, Inc. | 10 | $315 |
| Alkermes, Inc. | 6 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $143 |
| Lundbeck LLC | 6 | $129 |
| Vanda Pharmaceuticals Inc. | 4 | $126 |
Products named: Deep TMS, VRAYLAR, REXULTI, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, SPRAVATO.
Industry payments across CA — which companies pay providers there.
